Abstract:Experimentalallergic encephalomyelitis(EAE) is an animal model for inflammatory demyelinating autoimmune disease, i.e., multiple sclerosis (MS). In the present study, we investigated the antineuroinflammatory/neuroprotective effects of C16, an alpha upsilon beta 3 integrin-binding peptide, and recombinant rat ciliary neurotrophic factor (CNTF), a cytokine that was originally identified as a survival factor for neurons, in an acute rodent EAE model. In this model, C16 peptide was injected intravenously every day for 2 weeks, and CNTF was delivered into the cerebral ventricles with Alzet miniosmotic pumps. Disease severity was assessed weekly using a scale ranging from 0 to 5. Multiple histological and molecular biological assays were employed to assess inflammation, axonal loss, neuronal apoptosis, white matter demyelination, and gliosis in the brain and spinal cord of different groups. Our results showed that the EAE induced rats revealed a significant increase in inflammatory cells infiltration, while C16 treatment could inhibit the infiltration of leukocytes and macrophages down to 2/3-1/3 of vehicle treated EAE control (P < 0.05). The delayed onset of disease, reduced clinical score (P < 0.01) in peak stage and more rapid recovery also were achieved in C16 treated group. Besides impairing inflammation, CNTF treatment also exerted direct neuroprotective effects, decreasing demyelination and axon loss score (P < 0.05 versus vehicle treated EAE control), and reducing the neuronal death from 40 to 50% to 10 to 20% (P < 0.05). Both treatments suppressed the expression of cytokine tumor necrosis factor-alpha and interferon-gamma when compared with the vehicle control (P < 0.05). Combined treatment with C16 and CNTF produced more obvious functional recovery and neuroprotective effects than individually treatment (P < 0.05). These results suggested that combination treatment with C16 and CNTF, which target different neuroprotection pathways, may be an effective therapeutic alternative to traditional therapy.

Preparation and affinity purification of a novel, biologically active, CNTF fusion protein

Expression of a Fusion Protein of Human Ciliary Neurotrophic Factor and Soluble CNTF-Receptor and Identification of Its Activity

Construction of Recombinant NNMT Plasmid and Expression in E. Coli

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

[Construction of Recombinant GST-RCAS1 Fusion Gene and Its Expression in E. Coli].

Engineering a Pharmacologically Superior Form of Granulocyte-Colony-stimulating Factor by Fusion with Gelatin-Like-protein Polymer.

[Purification and Characterization of the Fusion Protein TGF-betaR II/Fc].

[Construction and Identification of Recombinant Adenovirus Expressing Rat Proteoglycan II].

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Heterologous high yield expression and purification of neurotensin and its functional fragment in Escherichia coli

A Novel TNFα Antagonizing Peptide-Fc Fusion Protein Designed Based on CDRs of TNFα Neutralizing Monoclonal Antibody

Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli

Fusion Protein of CDR Mimetic Peptide with Fc Inhibit TNF-α Induced Cytotoxicity

Characterization of a Fusion Protein Composed of the Extracellular Domain of c-kit and the Fc Region of Human IgG Expressed in a Baculovirus System

Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited THE INTERLEUKIN-6 RECEPTOR CAN SERVE AS AN α-RECEPTOR FOR CNTF

[Expression, Purification and Identification of Fusion Protein Mtslpr-Ig].

Construction, Identification and Application of Fusion Plasmid of Brain-Derived Neurotrophic Factor-Green Fluorescent Protein

Expression, refolding, and characterization of a novel recombinant dual human stem cell factor.

Purification and Characterization of Rgd Tumor-Homing Peptide Conjugated Human Tumor Necrosis Factor Alpha Over-Expressed in Escherichia Coli